
    
      ORION is a prospective, single arm, non-randomized, multicenter study. A subject could
      receive a maximum of 2 study stents for up to 2 target lesions. A maximum of 1 non-target
      lesion in 1 non-target vessel could be treated with a commercially approved treatment during
      the index procedure.
    
  